Read next
Digital Therapeutics Face Regulatory Hurdles in European Expansion
Reimbursement complexity and fragmented clinical validation standards slow adoption of prescription software applications.
Clinical AI Diagnostic Tools Encounter Regulatory Friction Over Algorithmic Drift
Regulators demand continuous post-market monitoring as healthcare AI models struggle to maintain accuracy across diverse demographic datasets.
GLP-1 Supply Shortages Accelerate Production Line Automation
Pharmaceutical manufacturers are deploying automated fill-finish capacity to meet surging global demand for weight-loss therapeutics.
Digital Biomarkers Gain Regulatory Traction for Clinical Trials
Continuous monitoring data from wearable devices is gaining formal acceptance as secondary endpoints in clinical drug studies.
Clinical Trial Automation Accelerates Target Discovery Timelines
Pharmaceutical companies are adopting automated screening and real-world data analytics to compress early-stage clinical trial schedules and reduce…
Clinical Trials Validate Dual-Targeting GLP-1 Therapeutics for Metabolic Disorders
Phase III data shows significant efficacy in glycemic control and cardiovascular risk reduction among adult populations.